These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8997576)

  • 21. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
    Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT;
    Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.
    McDonald MB; Protzko EE; Brunner LS; Morris TW; Haas W; Paterno MR; Comstock TL; Usner DW
    Ophthalmology; 2009 Sep; 116(9):1615-1623.e1. PubMed ID: 19643483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A multicenter randomized study of fusidic acid ophthalmic gel and rifamycine eyedrops in acute conjunctivitis].
    Adenis JP; Arrata M; Gastaud P; Limon S; Massin M
    J Fr Ophtalmol; 1989; 12(4):317-22. PubMed ID: 2697725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of six clinical phase III studies comparing lomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis.
    Jauch A; Fsadni M; Gamba G
    Graefes Arch Clin Exp Ophthalmol; 1999 Sep; 237(9):705-13. PubMed ID: 10447643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis in adults and children.
    DeLeon J; Silverstein BE; Allaire C; Gearinger LS; Bateman KM; Morris TW; Comstock TL
    Clin Drug Investig; 2012 May; 32(5):303-17. PubMed ID: 22420526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children.
    Silverstein BE; Allaire C; Bateman KM; Gearinger LS; Morris TW; Comstock TL
    Clin Ther; 2011 Jan; 33(1):13-26. PubMed ID: 21397770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study.
    Gallenga PE; Lobefalo L; Colangelo L; Della Loggia G; Orzalesi N; Velati P; Bujtar E; Ponte F; Damiani S; Bucci MG; Bonini S; Curatola MR; Palma LA; Bonomi L; Tomazzoli Gerosa L; Pagliarusco A; Milan E; Jauch A
    Ophthalmologica; 1999; 213(4):250-7. PubMed ID: 10420109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The treatment of acute infectious conjunctivitis with fusidic acid: a randomised controlled trial.
    Rietveld RP; ter Riet G; Bindels PJ; Bink D; Sloos JH; van Weert HC
    Br J Gen Pract; 2005 Dec; 55(521):924-30. PubMed ID: 16378561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of in situ-forming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: in vitro and in vivo studies.
    Charoo NA; Kohli K; Ali A
    J Pharm Sci; 2003 Feb; 92(2):407-13. PubMed ID: 12532390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis.
    Belfort R; Gabriel L; Martins Bispo PJ; Muccioli C; Zacharias Serapicos PC; Clark L; Bell B; Bartell J; Stroman DW; Höfling-Lima AL
    Adv Ther; 2012 May; 29(5):416-26. PubMed ID: 22562783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fusidic acid in other infections.
    Golledge C
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S11-5. PubMed ID: 10528782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fusidic acid vs ofloxacin prophylaxis before cataract surgery.
    Lofoco G; Quercioli P; Ciucci F; Bardocci A; De Gaetano C; Steigerwalt R
    Eur J Ophthalmol; 2005; 15(6):718-21. PubMed ID: 16329056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial isolates and their antimicrobial susceptibility pattern among patients with external ocular infections at Borumeda hospital, Northeast Ethiopia.
    Shiferaw B; Gelaw B; Assefa A; Assefa Y; Addis Z
    BMC Ophthalmol; 2015 Aug; 15():103. PubMed ID: 26268424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study.
    Karpecki P; Depaolis M; Hunter JA; White EM; Rigel L; Brunner LS; Usner DW; Paterno MR; Comstock TL
    Clin Ther; 2009 Mar; 31(3):514-26. PubMed ID: 19393842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Susceptibility of drug-resistant staphylococci isolated from different parts of the ocular anterior segment to common ophthalmic antibiotics].
    Yue J; Wang CM; Lyu JX; Jian SJ; Niu YY; Liu SS; Sun ST; Han L; Zhang HM
    Zhonghua Yan Ke Za Zhi; 2022 Aug; 58(8):598-605. PubMed ID: 35959604
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of acute neonatal bacterial conjunctivitis: a comparison of fucidic acid to chloramphenicol eye drops.
    Normann EK; Bakken O; Peltola J; Andréasson B; Buhl S; Sigg P; Nielsen K
    Acta Ophthalmol Scand; 2002 Apr; 80(2):183-7. PubMed ID: 11952486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute conjunctivitis. A comparison of fusidic acid viscous eye drops and chloramphenicol.
    Hørven I
    Acta Ophthalmol (Copenh); 1993 Apr; 71(2):165-8. PubMed ID: 8333258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of bacterial conjuntivitis with topical ciprofloxacin and norfloxacin: a comparative study].
    Chisari G; Sanfilippo M; Reibaldi M
    Infez Med; 2003 Mar; 11(1):25-30. PubMed ID: 12719667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ofloxacin vs tobramycin for the treatment of external ocular infection. Ofloxacin Study Group II.
    Gwon A
    Arch Ophthalmol; 1992 Sep; 110(9):1234-7. PubMed ID: 1520109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ciprofloxacin as treatment for conjunctivitis.
    Chisari G; Reibaldi M
    J Chemother; 2004 Apr; 16(2):156-9. PubMed ID: 15216950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.